Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Nehal Chopra’s Ratan Capital is Betting on These Stocks

Nehal Chopra is a graduate from the Wharton School of the University of Pennsylvania. In 2011, Tiger Management, led by Julian Robertson, seeded Nehal Chopra’s Ratan Capital. She has also worked as at  UBS and Lehman Brothers Holdings and then joined hedge fund firms Dmitry Balyasny’s Balyasny Asset Management and Ramius Capital Group, managed by Cowen Group. She launched Ratan Capital Management in 2009, which is a long-short equity fund. The fund exited 2013, with a portfolio value of $411.29 million, up from $336.74 million in the third quarter.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX)

In its latest 13F filing, Ratan Capital Management LP, has disclosed holding 474,200 shares of Valeant Pharmaceuticals International (NYSE:VRX), up from 409,700 shares held in the third quarter of 2013, . The fund’s tweak in the position has upped the value of the holding to $55.67 million from $42.75 million reported previously.Early this month, the multinational specialty pharmaceutical company has entered into a definitive agreement to acquire PreCision Dermatology, Inc for a total sum of $500 million.

Next on the list is the Massachusetts based CIRCOR International, Inc (NYSE:CIR). The fund now owns 603,000 shares of the company, worth $48.71 million. The stake has been significantly increased from 496,600 shares held in the third quarter. CIRCOR International, Inc (NYSE:CIR) manufactures, designs and markets valves and other highly engineered products. In the second week of February, the company declared cash dividend of $0.038 per share, payable on March 14, 2014.

In Post Holdings, Inc. (NYSE:POST), the manufacturer, marketer and distributor of branded ready-to-eat cereals,  Ratan has raised its stake to 820,100 shares, from 482,400 held earlier. The value of the stake amounts to $40.41 million. Post Holdings Inc exited the previous quarter with earnings of $0.02 per diluted share.

Forest Laboratories, Inc. (NYSE:FRX) occupied the fourth spot. The fund holds 639,091 shares of the company, a significant increase from 471,400 shares held in the third quarter. The value of the stake holding amounts to $38.35, which is equivalent to 9.32% of the fund’s equity portfolio. The New York based company is developer, manufacturer and seller of branded ethical drugs. Last week, Actavis Plc announced that it will acquire Forest Laboratories, Inc (NYSE:FRX) in an equity and cash transaction worth $25.0 billion.

Ratan Capital Management held the fifth largest stake in Allergan Inc (NYSE:AGN), a multi-specialty healthcare company. The fund significantly upped the position to 289,000 shares in the fourth quarter of last year from 150,000 shares held in the previous quarter. The value of its holdings totaled to $32.11 million, which is equivalent to 7.8% of the fund’s equity portfolio.

Disclosure:none

Recommended reading:

Fortress Investment Group Raises Position In Brookdale Senior Living Inc. (BKD)

Foxhaven Asset Management’s Top Picks From the Latest 13F

Insider Monkey’s Quarterly Newsletter is Out!

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!